Human Vaccine Adjuvant Research

Adjuvants for therapeutic and prophylactic vaccines

A vaccine adjuvant is used in the composition of a vaccine to increase, prolong, and modulate an immune response against the associated antigen. With our experience in animal health, we have tried to bring our expertise into human vaccine adjuvant research to encounter numerous possible diseases.
For more than 15 years, Country Best has offered adjuvant solutions for the animal health industries with safe and effective vaccine combinations. Now Country Best also focuses on the prevention of infectious diseases in human health industry. In 2020, the world has had a great impact due to the COVID-19 epidemic. We strive for the better of human health to help overcome this terrible disease by cooperation with Taiwan hospital in pre-clinical trials in mucosal human COVID-19 vaccines.
Our vaccine adjuvants follow Good Manufacturing Practices (GMP) with sterile grades manufactured under aseptic conditions in a pharmaceutical facility to ensure that each and every person enjoys a safe and healthy life.

Inquiry
  • Print
Therapeutic vaccines are administered to patients to assist the body in defending against existing diseases. They are used to treat cancers, autoimmune diseases, and various chronic infectious diseases.
 
Cbest offers injectable adjuvants for formulating effective therapeutic vaccines as stable emulsions, with specific antigens contained in the aqueous phase.
 
Prophylactic vaccines are administered to healthy populations to prevent infectious diseases. These vaccines may require adjuvants to enhance the immune response they induce and achieve adequate protection.

Related Products